Bone health in women with epilepsy

Pamela Crawford, Enrique A Serrano, M. Sazgar

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

A 55-year-old woman has been on carbamazepine for 30 years with excellent control of her partial-onset seizures. In the past when an attempt was made to switch her to lamotrigine or levetiracetam, she experienced seizure recurrence as soon as carbamazepine was tapered off. You order vitamin D levels which are borderline low and a DXA scan which shows osteoporosis of hip and thoracic spine. What is your advice to her for future management of her epilepsy in this context?.

Original languageEnglish (US)
Title of host publicationControversies in Caring for Women with Epilepsy: Sorting Through the Evidence
PublisherSpringer International Publishing
Pages159-167
Number of pages9
ISBN (Electronic)9783319291703
ISBN (Print)9783319291680
DOIs
StatePublished - Jan 1 2016

Keywords

  • Antiepileptic drugs (AEDs)
  • Bisphosphonates
  • Bone health
  • Bone-mineral density
  • Calcium
  • Carbamazepine
  • Changing AEDs
  • Dual-energy X-ray absorptiometry
  • DXA scan
  • Enzyme-inducing AEDs
  • Fractures
  • FRAX score
  • Hepatic microsomal enzyme-inducing drugs
  • Osteoporosis
  • Parathyroid hormone
  • Quality of life
  • Sudden unexpected death in epilepsy
  • Vitamin D
  • Women with epilepsy

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Bone health in women with epilepsy'. Together they form a unique fingerprint.

  • Cite this

    Crawford, P., Serrano, E. A., & Sazgar, M. (2016). Bone health in women with epilepsy. In Controversies in Caring for Women with Epilepsy: Sorting Through the Evidence (pp. 159-167). Springer International Publishing. https://doi.org/10.1007/978-3-319-29170-3_19